- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
The Iran War Exposes the Emptiness of American ‘Strength’ in East Asia
For decades Washington has advertised its air and naval supremacy as the indispensable guarantor of global order. Recent events have shown this to be little but increasingly expensive theater. The 2026 Iran War has paused not with Iranian capitulation but in a cascade...
